Evidence map›Paper›PMID 34502404›Full record

ArticleInternational journal of molecular sciences2021

Failure of Diphtheria Toxin Model to Induce Parkinson-Like Behavior in Mice.

Lucie Valek, Irmgard Tegeder

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lucie ValekInstitute of Clinical Pharmacology, Medical Faculty, Goethe-University, 60590 Frankfurt, Germany.ORCID 0000-0001-9154-8829
Irmgard TegederInstitute of Clinical Pharmacology, Medical Faculty, Goethe-University, 60590 Frankfurt, Germany.ORCID 0000-0001-7524-8025
Goethe University Frankfurt · DE

Funding

Deutsche Forschungsgemeinschaft CRC1039, A03Deutsche Forschungsgemeinschaft CRC1080, C02
6 · The paper itself

Abstract

Rodent models of Parkinson's disease are based on transgenic expression of mutant synuclein, deletion of PD genes, injections of MPTP or rotenone, or seeding of synuclein fibrils. The models show histopathologic features of PD such as Lewi bodies but mostly only subtle in vivo manifestations or systemic toxicity. The models only partly mimic a predominant loss of dopaminergic neurons in the substantia nigra. We therefore generated mice that express the transgenic diphtheria toxin receptor (DTR) specifically in DA neurons by crossing DAT-Cre mice with Rosa26 loxP-STOP-loxP DTR mice. After defining a well-tolerated DTx dose, DAT-DTR and DTR-flfl controls were subjected to non-toxic DTx treatment (5 × 100 pg/g) and subsequent histology and behavioral tests. DAT protein levels were reduced in the midbrain, and tyrosine hydroxylase-positive neurons were reduced in the substantia nigra, whereas the pan-neuronal marker NeuN was not affected. Despite the promising histologic results, there was no difference in motor function tests or open field behavior. These are tests in which double mutant Pink1

Indexed as

alpha-SynucleinAnimalsBrainCorpus StriatumDiphtheria ToxinDisease Models, AnimalDopamineDopaminergic NeuronsFemaleHeparin-binding EGF-like Growth FactorMaleMiceMice, Inbred C57BLMice, TransgenicParkinson DiseaseParkinsonian Disordersalpha-SynucleinDiphtheria ToxinDopamineHeparin-binding EGF-like Growth FactorTyrosine 3-MonooxygenaseCre-recombinasediphtheria toxindopamine transportermotor functionsopen field behaviorSLC6a3tyrosine hydroxylase

Identifiers

PMID34502404
PMCPMC8430633
OpenAlexW3197497391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.